Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2152437

CCCCCCCCCCCC(CCCCCCCC)N(C)C.Cl

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
OPRM1 known ✓ P35372 1/20 0.40
DNM1 Q05193 5/20 0.46
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
THRB P10828 1/20 0.42
PLA2G1B P04054 1/20 0.40
PLA2G2A P14555 1/20 0.40
GPR84 Q9NQS5 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5603640 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL18141496 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL2247770 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL8958524 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL1123506 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL18139514 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL18140517 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL18141133 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL2201080 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1
Hydrochloric Acid SCHEMBL18141378 1.00 DNM1 (0.46) DNM1LMNATSHRTHRBOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119586627-A Disinfectant combination and disinfectant for hatching egg disinfection and application thereof 洛阳沃普森生物工程有限公司 2025-03-11 CN claimed
CN-111718716-A Nanostructures with inorganic ligands for electroluminescent devices 纳米系统公司 2020-09-29 CN claimed
CN-107556521-B Three-dimensional porous sponge composite material loaded with nano zinc oxide 赵兵 2020-06-02 CN claimed
US-6323036-B1 COLORIMETRIC REAGENT ADAPTED FOR THE SPECTROPHOTOMETRIC ANALYSIS OF A SOLUTION OF LEAD IONS EXTRACTED FROM A BIOLOGICAL MATRIX BAYER CORPORATION 2001-11-27 US claimed
US-4073888-A SPORICIDAL PETTIBONE LABORATORIES, INC. (US) 1978-02-14 US claimed
US-12539272-B2 Microemulsion-based vaccine delivery system, preparation method therefor and use thereof SICHUAN UNIVERSITY (CN) 2026-02-03 US disclosed
WO-2025089725-A1 SMOKING ARTICLE AND AEROSOL-GENERATING DEVICE USING SAME 주식회사 이엠텍 2025-05-01 WO disclosed
CN-119586627-A Disinfectant combination and disinfectant for hatching egg disinfection and application thereof 洛阳沃普森生物工程有限公司 2025-03-11 CN disclosed
WO-2024242252-A1 SEMI-SOLID OR SOLID BODY FOR ELECTRONIC CIGARETTE AND METHOD FOR MANUFACTURING SAME 주식회사 이엠텍 2024-11-28 WO disclosed
WO-2024232553-A1 SOLID SUBSTANCE FOR ELECTRONIC CIGARETTE AND METHOD FOR PRODUCING SAME 주식회사 이엠텍 2024-11-14 WO disclosed
US-20230086736-A1 MICROEMULSION-BASED VACCINE DELIVERY SYSTEM, PREPARATION METHOD THEREFOR AND USE THEREOF SICHUAN UNIVERSITY (CN) 2023-03-23 US disclosed
CN-115702122-A Use of chloramines and cationic polymers in water treatment 巴克曼实验室国际公司 2023-02-14 CN disclosed
EP-1787627-A1 Anti-microbial dental impression material 3M Innovative Properties Company (US) 2007-05-23 EP disclosed
EP-0814336-B1 Reagents and methods for releasing and measuring lead from biological matrices BAYER AG (US) 2004-11-10 EP disclosed
US-5891736-A SENSITIVE QUANTITATIVE ANALYSIS BY MIXING BLOOD OR OTHER FLUID WITH ION EXTRACTING ACID AND SOLUBILIZING ALKALI METAL SALT HAVING ANION OF NITRATE, CHLORIDE, OR BROMIDE; FORMING ANALYZABLE SUPERNATANT AND RESIDUAL PRECIPITATE BAYER CORPORATION (US) 1999-04-06 US disclosed
EP-0814336-A2 Reagents and methods for releasing and measuring lead from biological matrices Bayer Corporation (US) 1997-12-29 EP disclosed
EP-0238413-B1 A TREATING PROCESS FOR WOOD PRESERVATION AND A WOOD PRESERVATIVE FOR THE PROCESS KATAYAMA CHEMICAL WORKS LTD. (JP) 1990-08-16 EP disclosed
EP-0238413-A1 A treating process for wood preservation and a wood preservative for the process KATAYAMA CHEMICAL WORKS LTD. (JP) 1987-09-23 EP disclosed
US-4368237-A ORGANIC SOLVENT-FREE FUJI PHOTO FILM CO., LTD. (JP) 1983-01-11 US disclosed
US-4073888-A SPORICIDAL PETTIBONE LABORATORIES, INC. (US) 1978-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12539272-B2 Microemulsion-based vaccine delivery system, preparation method therefor and use thereof SLC39A11, CD81, CD4 OPRM1 2352/4885DNM1 1240/4885LMNA 4226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.